Changes in temperature and water depth of a small mountain lake during the past 3000 years in Central Kamchatka reflected by a chironomid record

© 2016 Elsevier Ltd and INQUA We investigated chironomid assemblages of a well-dated sediment core from a small seepage lake situated at the eastern slope of the Central Kamchatka Mountain Chain, Far East Russia. The chironomid fauna of the investigated Sigrid Lake is dominated by littoral taxa that are sensitive to fluctuations of the water level. Two groups of taxa interchangeably dominate the record responding to the changes in the lake environment during the past 2800 years. The first group of littoral phytophilic taxa includes Psectrocladius sordidellus-type, Corynoneura arctica-type and Dicrotendipes nervosus-type. The abundances of the taxa from this group have the strongest influence on the variations of PCA 1, and these taxa mostly correspond to low water levels, moderate temperatures and slightly acidified conditions. The second group of taxa includes Microtendipes pedellus-type, Tanytarsus lugens-type, and Tanytarsus pallidicornis-type. The variations in the abundances of these taxa, and especially of M. pedellu s-type, are in accordance with PCA 2 and correspond to the higher water level in the lake, more oligotrophic and neutral pH conditions. Water depths (WD) were reconstructed, using a modern chironomid-based temperature and water depth calibration data set (training set) and inference model from East Siberia (Nazarova et al., 2011). Mean July air temperatures (T July) were inferred using a chironomid-based temperature inference model based on a modern calibration data set for the Far East (Nazarova et al., 2015). The application of transfer functions resulted in reconstructed T July fluctuations of approximately 3 °C over the last 2800 years. Low temperatures (11.0–12.0 °C) were reconstructed for the periods between ca 1700 and 1500 cal yr BP (corresponding to the Kofun cold stage) and between ca 1200 and 150 cal yr BP (partly corresponding to the Little Ice Age [LIA]). Warm periods (modern T July or higher) were reconstructed for the periods between ca 2700 and 1800 cal yr BP, 1500 and 1300 cal yr BP and after 150 cal yr BP. WD reconstruction revealed that the lake level was lower than its present level at the beginning of the record between ca 2600 and 2300 cal yr BP and ca 550 cal yr BP. Between ca 2300 and 700 cal yr BP as well as between 450 and 150 cal yr BP, the lake level was higher than it is today, most probably reflecting more humid conditions

Changes in temperature and water depth of a small mountain lake during the past 3000 years in Central Kamchatka reflected by a chironomid record

© 2016 Elsevier Ltd and INQUA.We investigated chironomid assemblages of a well-dated sediment core from a small seepage lake situated at the eastern slope of the Central Kamchatka Mountain Chain, Far East Russia. The chironomid fauna of the investigated Sigrid Lake is dominated by littoral taxa that are sensitive to fluctuations of the water level. Two groups of taxa interchangeably dominate the record responding to the changes in the lake environment during the past 2800 years. The first group of littoral phytophilic taxa includes Psectrocladius sordidellus-type, Corynoneura arctica-type and Dicrotendipes nervosus-type. The abundances of the taxa from this group have the strongest influence on the variations of PCA 1, and these taxa mostly correspond to low water levels, moderate temperatures and slightly acidified conditions. The second group of taxa includes Microtendipes pedellus-type, Tanytarsus lugens-type, and Tanytarsus pallidicornis-type. The variations in the abundances of these taxa, and especially of M. pedellus-type, are in accordance with PCA 2 and correspond to the higher water level in the lake, more oligotrophic and neutral pH conditions. Water depths (WD) were reconstructed, using a modern chironomid-based temperature and water depth calibration data set (training set) and inference model from East Siberia (Nazarova et al., 2011). Mean July air temperatures (T July) were inferred using a chironomid-based temperature inference model based on a modern calibration data set for the Far East (Nazarova et al., 2015). The application of transfer functions resulted in reconstructed T July fluctuations of approximately 3 °C over the last 2800 years. Low temperatures (11.0-12.0 °C) were reconstructed for the periods between ca 1700 and 1500 cal yr BP (corresponding to the Kofun cold stage) and between ca 1200 and 150 cal yr BP (partly corresponding to the Little Ice Age [LIA]). Warm periods (modern T July or higher) were reconstructed for the periods between ca 2700 and 1800 cal yr BP, 1500 and 1300 cal yr BP and after 150 cal yr BP. WD reconstruction revealed that the lake level was lower than its present level at the beginning of the record between ca 2600 and 2300 cal yr BP and ca 550 cal yr BP. Between ca 2300 and 700 cal yr BP as well as between 450 and 150 cal yr BP, the lake level was higher than it is today, most probably reflecting more humid conditions

French national cohort of first use of dalbavancin: a high proportion of off-label use

Dalbavancin is a glycopeptide antibiotic with a long half-life, recently marketed in Europe for skin and soft tissue infections (SSTI), but real-life use is not well-known. We aimed to describe all first prescriptions in France over an 18-month period. We performed a retrospective study on all adult patients who received at least one dose of dalbavancin from July 1, 2017 to September 31, 2018. Data were collected thanks to a standard questionnaire. Failure was defined as: persistent or reappearance of signs of infection; and/or switch to suppressive antibiotic treatment; and/or death from infection. We included 75 patients from 29 French hospitals. Main indications were bone and joint infections (BJIs) (64.0%), endocarditis (25.3%), and SSTIs (17.3%). Main bacteria involved were: Staphylococcus aureus (51.4%), including methicillin-resistant S. aureus (MRSA) (19.4%); and coagulase-negative staphylococci (CNS) (44.4%). Median MICs for staphylococci to vancomycin and dalbavancin ranged from 0.875 mg/L to 2.0 mg/L, and 0.040 mg/L to 0.064 mg/L, respectively. Dalbavancin was used after a mean of 2.3 ± 1.2 lines of antimicrobial treatment. Main treatment regimens for dalbavancin were a weekly 2-dose regimen (1500mg each) in 38 (53.2%) cases, and a single-dose regimen (1500mg) in 13 (18.3%) cases. Overall, at the patients\u27 last visit, clinical cure was observed in 54/72 patients, while failure was found in 14/72 patients. First uses of dalbavancin in France were mostly off-label. Most of them were due to BJIs, and often as rescue therapy for severe infections. Even in off-label situations, dalbavancin seems safe and effective

J Clin Med

BACKGROUND: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. METHODS: We evaluate the effect of coffee's active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. RESULTS: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). CONCLUSIONS: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742

Antibiotiques chez le patient insuffisant rénal : actualisation des adaptations posologiques à la pratique clinique en infectiologie

Antibiotic prescription in chronic kidney disease patients poses a twofold problem. The appropriate use of antibacterial agents is essential to ensure efficacy and to prevent the emergence of resistance, and dosages should be adapted to the renal function to prevent adverse effects. SiteGPR is a French website for health professionals to help with prescriptions to chronic kidney disease patients. A working group of infectious disease specialists and nephrology pharmacists reviewed the indications, dosing regimens, administration modalities, and dose adjustments of antibiotics marketed in France for patients with renal failure. Data available on the SiteGPR website and detailed in the present article aims to provide an evidence-based update of infectious disease recommendations to health professionals managing patients with chronic kidney disease

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Background: We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases. Methods: We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded. Results: No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5–528.7, P = 1.1 × 10−4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3–8.2], P = 2.1 × 10−4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1–2635.4], P = 3.4 × 10−3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3–8.4], P = 7.7 × 10−8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10−5). Conclusions: Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60&nbsp;years old

Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey

Antimicrobial stewardship (AMS) and Infection prevention and control (IPC) are two key complementary strategies that combat development and spread of antimicrobial resistance. The ESGAP (ESCMID Study Group for AMS), EUCIC (European Committee on Infection Control) and TAE (Trainee Association of ESCMID) investigated how AMS and IPC activities and training are organized, if present, at national level in Europe. From February 2018 to May 2018, an internet-based cross-sectional survey was conducted through a 36-item questionnaire, involving up to three selected respondents per country, from 38 European countries in total (including Israel), belonging to the ESGAP/EUCIC/TAE networks. All 38 countries participated with at least one respondent, and a total of 81 respondents. Education and involvement in AMS programmes were mandatory during the postgraduate training of clinical microbiology and infectious diseases specialists in up to one-third of countries. IPC was acknowledged as a specialty in 32% of countries. Only 32% of countries had both guidance and national requirements regarding AMS programmes, in contrast to 61% for IPC. Formal national staffing standards for AMS and IPC hospital-based activities were present in 24% and 63% of countries, respectively. The backgrounds of professionals responsible for AMS and IPC programmes varied tremendously between countries. The organization and training of AMS and IPC in Europe are heterogeneous and national requirements for activities are frequently lacking